Novartis Heart Drug Hit by Scandal in Japan Japanese researchers have withdrawn studies that promoted the benefits of one of Novartis’s best selling drugs, the heart medicine Diovan (valsartan). The news of the withdrawal came after university-led investigations found data had been manipulated to create false results, according … Continue reading ?
Sept. 16, 2013 - NewsInferno
Daniel Vasella in Forbes It looks better than Diovanin terms of efficacy, Vasella says of aliskiren, comparing it with the company's big-selling Diovan hypertension drug. "If the drug proves to be as good as it looks now, it certainly would be a...